Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fulgent Genetics Inc (NQ: FLGT )

20.99 -0.25 (-1.18%)
Streaming Delayed Price Updated: 12:15 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 171,683
Open 20.50
Bid (Size) 20.98 (2)
Ask (Size) 21.04 (1)
Prev. Close 21.24
Today's Range 20.50 - 21.50
52wk Range 19.88 - 44.09
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Fulgent Reports First Quarter 2024 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire

Performance

YTD
-28.34%
-28.34%
1 Month
-1.32%
-1.32%
3 Month
-16.01%
-16.01%
6 Month
-11.77%
-11.77%
1 Year
-28.44%
-28.44%

More News

Read More
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Earnings Preview: Fulgent Genetics
Via Benzinga
Why Is Fulgent Genetics Stock Moving Higher Today?
Via Benzinga
Earnings Outlook For Fulgent Genetics
Via Benzinga
Fulgent Genetics Earnings Perspective: Return On Capital Employed
Via Benzinga
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
From Fulgent Genetics, Inc.
Via Business Wire
The 3 Best Digital Health Stocks for Personalized Medicine
Via InvestorPlace
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Earnings Scheduled For November 3, 2023
Via Benzinga
Fulgent Reports Third Quarter 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
From Fulgent Genetics, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Fulgent Reports Second Quarter 2023 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
Earnings Scheduled For August 4, 2023
Via Benzinga
Exagen Inc. Appoints Paul Kim to Board of Directors
From Exagen Inc.
Via GlobeNewswire
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
From Fulgent Genetics, Inc.
Via Business Wire
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
Via The Motley Fool
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
From Fulgent Genetics, Inc.
Via Business Wire
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Via The Motley Fool
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.